Cardiac anesthesia risk management. Multicenter outcome research

Area of Science:

• Cardiology
• Neurosurgery
• Health Economics

Background:

• Perioperative cardiovascular morbidity is a major healthcare challenge, impacting millions of patients undergoing surgery annually.
• Current costs associated with perioperative cardiovascular morbidity are substantial, encompassing both in-hospital and post-hospitalization care.
• Despite advancements in early detection, perioperative heart and brain infarctions remain critical issues.

Purpose of the Study:

• To highlight the significant burden of perioperative cardiovascular morbidity and its associated costs.
• To emphasize the need for large-scale therapeutic trials to improve patient outcomes.
• To introduce the McSPI Research Group's focus on addressing heart attack and stroke in the perioperative setting.

Main Methods:

• Review of existing data on perioperative cardiovascular morbidity and associated healthcare costs.
• Discussion of past and present strategies for managing perioperative cardiovascular and central nervous system morbidity.
• Introduction of the McSPI Research Group as a platform for future research.

Main Results:

• Perioperative cardiovascular morbidity incurs significant financial costs, estimated in the billions of dollars annually.
• Over one million patients in the U.S. experience postsurgical cardiovascular morbidity each year.
• Existing technologies for early detection of infarction surrogates have not sufficiently resolved the problem of perioperative infarctions.

Conclusions:

• Future advancements in perioperative care necessitate large-scale therapeutic trials.
• The McSPI Research Group aims to identify effective therapies for perioperative cardiovascular and neurological events.
• The group also focuses on fostering the academic development of clinical investigators in this field.